Search PubMed⌕ Search

Biomedical subjects

M H Keeler

Publications and source records attributed to M H Keeler.

At least 19 recordsLinked to original sources

The effect of lithium carbonate on alcoholism in 20 male patients with concurrent major affective disorder.

Descriptively, Alcoholism and Bipolar Affective Disorders may resemble each other. Both disorders are marked by a chronic course with periods of remission and relapse and often profound affective disturbance. Since lithium carbonate has shown a remarkable efficacy in the treatment or prophylaxis of Bipolar Affective Disorder, it would be natural to hope for some similar dramatic benefit in alcoholism. Two controlled studies have been published in English in which lithium salts showed some benefits on drinking in "depressed" patients with alcoholism. Other studies published in the literature have been less certain but cautiously positive about some anti-alcohol effects of lithium. Favorable anecdotal reports have continued to appear, and there is every indication that lithium may be prescribed quite widely in alcoholism. It is remarkable that since lithium has a very specific therapeutic effect on mania and a much less clear effect on depression that no one has previously reported on manic (or Bipolar) patients with problem drinking or alcoholism in a systematic fashion. This lack of data may perhaps result from difficulty in locating such a population. In a previous publication, two of the present authors reported little benefit on alcohol symptoms in a small number of patients with mania who they treated for 6 or more months. In the present study, we have extended this first report to a group of 20 Bipolar or manic patients with concurrent diagnosis of alcoholism or abusive drinking, all of whom were followed on lithium for not less than one year.

Adult↗

Are all recently detoxified alcoholics depressed?

Reports of the prevalence of depression among alcoholics vary from 3% to 98%; the authors attribute this variation to the use of different diagnostic criteria. They used clinical diagnosis, the Hamilton Depression Rating Scale, the Zung Self-Rating Depression Scale, and the MMPI to diagnose 35 men recently withdrawn from alcohol. The percentages of depression diagnosed were 8.6%, 28%, 66%, and 43%, respectively. The authors point out that the Hamilton, Zung, and MMPI scales are not diagnostic of depression in themselves and that accurate diagnosis of depression in alcoholics will reduce inappropriate treatment of nondepressed alcoholics and ensure careful treatment of the truly depressed.

Alcoholism↗

Selection among benzodiazepines for alcohol withdrawal.

Four pharmacologic differences among the benzodiazepines, which are the drugs of choice to conduct alcohol withdrawal, guide selection of the appropriate one: chlordiazepoxide, diazepam, oxazepam, or chlorazepate. Bases for selection include: (1) availability of other than oral dosage forms; (2) differences in additive effect with alcohol in producing central nervous system depression; (3) differences in anticonvulsant effect; and (4) differences in duration of effect in the body (ie, half-life). Decreasing dosage schedules are preferred to a steady dosage. Illustrative dosage schedules for using chlordiazepoxide and diazepam to conduct alcohol withdrawal are given.

Administration, Oral↗

Medical practice without antianxiety drugs.

The benzodiazepines and hydroxyzine were removed from a statewide Medicaid pharmacopeia. Barbiturate sedatives, hypnotic and antipsychotic medication, and tricyclic antidepressants remained available, but no substitution was made for about two-thirds of the deleted ataractic medications. The authors conclide that most physicans regard ataractics as unique and do not use them interchangeably with the other drugs.

Attitude of Health Personnel↗